Competitive strategies in life sciences: biobetters versus biosimilars

Competitive strategies in life sciences: biobetters versus biosimilars

Gregory K. Bell
Life Sciences | Pharmaceuticals

A discussion, moderated by Financier Worldwide, on competitive strategies in the life sciences sector between Gregory Bell at Charles River Associates, Rajeshwari Hariharan at Rajeshwari & Associates, and Paul A. Calvo at Sterne, Kessler, Goldstein & Fox P.L.L.C.

Financier Worldwide